Soleva Pharma seeks to revitalize branded oncology supportive care products with strong but unrealized commercial potential, and to accelerate the development of late-stage supportive care product candidates, to benefit underserved cancer patient populations.
Supportive care in oncology is a broad term that is composed of indications that are either a symptom of a patient’s cancer or a side effect of cancer treatment. The most prominent cancer supportive care indications include oral mucositis (OM); chemotherapy-induced nausea and vomiting (CINV), chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), cancer cachexia and bone metastases.
Company Details
- Founded
- -
- Address
- Robbinsville, New Jersey, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.solevapharma.com
- Keywords
- Raleigh.
- HQ
- Robbinsville, New Jersey
Soleva Pharma Questions
Soleva Pharma's website is http://www.solevapharma.com
Soleva Pharma's LinkedIn profile is https://www.linkedin.com/company/soleva-pharma
Soleva Pharma's industry is
Pharmaceutical Manufacturing
Soleva Pharma's top competitors are
Towne U.s.,
Healthy Interactions,
Viscient Bio Inc,
Teva Pharmaceuticals,
Growth Verticals,
Chorus By Zoominfo,
Ambrx,
Wcg,
Oncobay Clinical (Now Kapadi),
Doublezero Foundation.
Soleva Pharma's categories are Pharmaceutical Manufacturing
Soleva Pharma's founding year is 2018
